Trump announces Alex Azar as health secretary nominee

WASHINGTON, Nov 13 (Reuters) - President Donald Trump on Monday said he will nominate former pharmaceutical executive Alex Azar to serve as U.S. Health and Human Services secretary, saying Azar would push to lower the price of medicines.

If confirmed, Azar also would take the lead in implementing Trump's campaign promise to dismantle the Affordable Care Act, the 2010 healthcare overhaul passed under former Democratic President Barack Obama.

Trump, who is in the Philippines on a diplomatic trip, announced his intention to nominate Azar on Twitter by saying he would "be a star for better healthcare and lower drug prices."

Azar worked at Eli Lilly for a decade, including five years as president of its USA affiliate Lilly USA unit, and left the company in January, according to his LinkedIn page.

RELATED: Members past and present of President Trump's inner circle

29 PHOTOS
Members past and present of President Trump's inner circle
See Gallery
Members past and present of President Trump's inner circle
Ivanka Trump: First daughter and presidential adviser
Gen. John Kelly: Former Secretary of Homeland Security, current White House chief of staff
Steve Bannon: Former White House chief strategist, no longer with the Trump administration
Jared Kushner: Son-in-law and senior adviser
Kellyanne Conway: Former Trump campaign manager, current counselor to the president
Reince Priebus: Former White House chief of staff, no longer with the Trump administration
Anthony Scaramucci: Former White House communications director, no longer with the Trump administration
Sarah Huckabee Sanders: White House press secretary
Donald Trump Jr.: First son to President Trump
Sean Spicer: Former White House press secretary, soon to be no longer with the Trump administration
Jeff Sessions: U.S. attorney general
Steve Mnuchin: Secretary of Treasury
Paul Manafort: Former Trump campaign chairman
Carter Page: Former foreign policy adviser to Trump's presidential campaign
Omarosa Manigault: Director of communications for the Office of Public Liaison
Melania Trump: Wife to President Trump and first lady of the United States
Jason Miller: Former White House communications director, no longer with the Trump administration
Hope Hicks: White House Director of Strategic Communications
Mike Dubke: Former White House communications director, no longer with the Trump administration
Stephen Miller: Trump senior policy adviser
Corey Lewandowski: Former Trump campaign manager
Eric Trump: Son to President Trump
Rex Tillerson: Secretary of State
Michael Flynn: Former National Security Advisor, no longer with the Trump administration
Sebastian Gorka: Former deputy assistant to the president in the Trump administration, no longer in his White House role
Roger Stone: Former Trump campaign adviser, current host of Stone Cold Truth
Betsy DeVos: U.S. Education Secretary
Gary Cohn, director of the U.S. National Economic Council, walks toward Marine One on the South Lawn of the White House in Washington, D.C., U.S., on Wednesday, July 5, 2017. President Donald Trump's encounter this week at the Group of 20 summit with Russian leader Vladimir Putin is raising concerns among veteran American diplomats and analysts about a mismatch between a U.S. president new to global affairs and a wily former Soviet spymaster. Photographer: Andrew Harrer/Bloomberg via Getty Images
HIDE CAPTION
SHOW CAPTION
of
SEE ALL
BACK TO SLIDE

He also served several years on the board of directors of the Biotechnology Innovation Organization, a drug industry lobbying group, and earlier was general counsel and deputy secretary for Health and Human Services under former Republican President George W. Bush.

In February, Azar founded a consulting agency that specialized in biopharmaceutical and healthcare companies, his LinkedIn page said.

Azar's nomination comes after Trump's initial health secretary, former U.S. Representative Tom Price, resigned in September amid criticism over his use of expensive taxpayer-funded private charter jets for government travel instead of cheaper commercial flights.

Azar's nomination must be approved by the U.S. Senate, which is controlled by Trump's fellow Republicans. Democrats and other critics are likely to raise questions about the administration's seriousness about lowering drug prices with a former industry executive leading such a charge. (Reporting by Susan Heavey; Editing by Chizu Nomiyama and Bill Trott)

Read Full Story

Sign up for Breaking News by AOL to get the latest breaking news alerts and updates delivered straight to your inbox.

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.